Sotagliflozin
As a dual inhibitor of SGLT-1 and SGLT-2, Sotagliflozin can reduce postprandial blood glucose, increase GLP-1 and promote urinary glucose excretion.
| Catalog Number | API1018899041 |
| Alternative Name(s) | (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2-H-pyran-3,4,5-triol;CS-1853;LX4211;LX4211;LX4211;LX4211;LX-4211;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4Chemicalbook-ethoxybenzyl)phenyl)-6-(Methylthio)tetrahydro-2H-pyran-3,4,5-triol;(5S)-Methyl5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-beta-L-xylopyranoside;Sotagliflozin;LX4211/LX-4211 |
| Research Area | Hypoglycemic APIs |
| Molecular Formula | C21H25ClO5S |
| CAS# | 1018899-04-1 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/sotagliflozin-item-11745.html |